Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

AGX804 2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4)

This E. coli recombinant protein , Cat. No. AGX804 is tested for use in Lateral Flow Assay.

AGX804
1 mg  
Purchase on Sigma-Aldrich

Přehled

Replacement Information
Description
Catalogue NumberAGX804
Description2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4)
Alternate Names
  • SARS-CoV
  • SARS-CoV-2
Background InformationCoronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleocapsid antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).
References
Product Information
FormatPurified
PresentationPurified protein in 10 mM Phosphate buffer, 150 mM NaCl with no preservatives, pH 7.4.
Quality LevelMQ100
Applications
ApplicationThis E. coli recombinant protein , Cat. No. AGX804 is tested for use in Lateral Flow Assay.
Key Applications
  • Immunodiffusion
Application NotesOther recommended antigen products for lateral flow application are AGX806 or AGX808.
Biological Information
CloneN/A
ConcentrationPlease refer to guidance on suggested starting dilutions and/or titers per application and sample type.
SpecificitySARS-CoV-2
Purification MethodColumn Purification
UniProt Number
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles.
Packaging Information
Material Size1 mg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Katalogové číslo GTIN
AGX804 04061842457830

Documentation

2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4) MSDS

Title

Safety Data Sheet (SDS) 

2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4) Certificates of Analysis

TitleLot Number
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4) - 3542459 3542459
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4) - 3560625 3560625
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4) - 3593155 3593155
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4) - 3604246 3604246
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4) - 3671314 3671314
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4) - 3701843 3701843
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4) - 3702319 3702319
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4) - 3791998 3791998
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4) - 3836980 3836980
2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-4) - 3870085 3870085
Show more